Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in ...
Phase I and Pharmacokinetic Study of the Oral Farnesyl Transferase Inhibitor SCH 66336 Given Twice Daily to Patients With Advanced Solid Tumors PURPOSE: Immune complexes (IC) containing the ...
In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...
ELRIG 2025: Dual-view light-sheet imaging enables 4D glioblastoma spheroid assays for drug discovery
A collaboration between the University of Edinburgh and Imperial College London has used a dual-view oblique plane ...
Adherent cell assays have lagged behind in automation, slowing drug discovery. Semarion’s SemaCyte® microcarrier platform streamlines these workflows by making adherent cells assay-ready, improving ...
This article is based on a poster originally authored by Yongyang Huang, Ning Guo, Mackenzie Pierce, Leo Chan, Bo Lin and Yi Yang, which was presented at ELRIG Drug Discovery 2024 in affiliation with ...
Partillion Bioscience provides Nanovials, engineered microparticles that serve as suspendable reaction compartments for individual cells. Nanovials come in 35 µm or 50 µm diameters, and different ...
Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in angioimmunoblastic T cell lymphoma (AITL), a type of nodal T cell lymphoma, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback